An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis
This study has been completed.
Information provided by:
First received: May 17, 2005
Last updated: May 28, 2009
Last verified: May 2009
The purpose of this multicenter, open-label, prospective study is to evaluate the effectiveness and safety of etanercept in the treatment of subjects with psoriasis.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis|
Resource links provided by NLM:
Further study details as provided by Amgen:
Contacts and Locations